141 related articles for article (PubMed ID: 28410658)
1. The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly.
Kollack-Walker S; Liu CY; Fleisher AS
Neurol Clin; 2017 May; 35(2):231-262. PubMed ID: 28410658
[TBL] [Abstract][Full Text] [Related]
2. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
Atri A
Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
[TBL] [Abstract][Full Text] [Related]
3. Imaging beta-amyloid burden in aging and dementia.
Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
[TBL] [Abstract][Full Text] [Related]
4. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
5. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
6. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
Villemagne VL; Rowe CC
J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of brain amyloid in dementia: a review.
Quigley H; Colloby SJ; O'Brien JT
Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging in Dementias.
Mahalingam S; Chen MK
Semin Neurol; 2019 Apr; 39(2):188-199. PubMed ID: 30925612
[TBL] [Abstract][Full Text] [Related]
9. The use of CT in dementia.
Pasi M; Poggesi A; Pantoni L
Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S6-12. PubMed ID: 21729420
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
11. Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging.
Hatashita S; Yamasaki H
J Alzheimers Dis; 2010; 21(3):995-1003. PubMed ID: 20693641
[TBL] [Abstract][Full Text] [Related]
12. Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
Torosyan N; Silverman DH
Semin Nucl Med; 2012 Nov; 42(6):415-22. PubMed ID: 23026363
[TBL] [Abstract][Full Text] [Related]
13. Current and future uses of neuroimaging for cognitively impaired patients.
Small GW; Bookheimer SY; Thompson PM; Cole GM; Huang SC; Kepe V; Barrio JR
Lancet Neurol; 2008 Feb; 7(2):161-72. PubMed ID: 18207114
[TBL] [Abstract][Full Text] [Related]
14. Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.
Apostolova I; Lange C; Roberts A; Igel HJ; Mäurer A; Liese S; Estrella M; Prasad V; Stechl E; Lämmler G; Steinhagen-Thiessen E; Buchert R
J Alzheimers Dis; 2017; 56(1):197-204. PubMed ID: 27911313
[TBL] [Abstract][Full Text] [Related]
15. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.
Nasrallah IM; Wolk DA
J Nucl Med; 2014 Dec; 55(12):2003-11. PubMed ID: 25413136
[TBL] [Abstract][Full Text] [Related]
16. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
Döbert N; Pantel J; Frölich L; Hamscho N; Menzel C; Grünwald F
Dement Geriatr Cogn Disord; 2005; 20(2-3):63-70. PubMed ID: 15908747
[TBL] [Abstract][Full Text] [Related]
18. A review of the default mode network in aging and dementia based on molecular imaging.
Ouchi Y; Kikuchi M
Rev Neurosci; 2012 Feb; 23(3):263-8. PubMed ID: 22752783
[TBL] [Abstract][Full Text] [Related]
19. PET imaging in the assessment of normal and impaired cognitive function.
Silverman DH; Alavi A
Radiol Clin North Am; 2005 Jan; 43(1):67-77, x. PubMed ID: 15693648
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
Hampel H
J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
